STIBURKOVA, Blanka, Jana BOHATA, Iveta MINARIKOVA, Andrea MANCIKOVA, Jiri VAVRA, Vladimir KRYLOV and Zdeněk DOLEŽEL. Clinical and Functional Characterization of a Novel URAT1 Dysfunctional Variant in a Pediatric Patient with Renal Hypouricemia. Applied Sciences-Basel. BASEL: MDPI, 2019, vol. 9, No 17, p. 1-8. ISSN 2076-3417. Available from: https://dx.doi.org/10.3390/app9173479.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Clinical and Functional Characterization of a Novel URAT1 Dysfunctional Variant in a Pediatric Patient with Renal Hypouricemia
Authors STIBURKOVA, Blanka (203 Czech Republic, guarantor), Jana BOHATA (203 Czech Republic), Iveta MINARIKOVA (203 Czech Republic), Andrea MANCIKOVA (203 Czech Republic), Jiri VAVRA (203 Czech Republic), Vladimir KRYLOV (203 Czech Republic) and Zdeněk DOLEŽEL (203 Czech Republic, belonging to the institution).
Edition Applied Sciences-Basel, BASEL, MDPI, 2019, 2076-3417.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30217 Urology and nephrology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.474
RIV identification code RIV/00216224:14110/19:00110982
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/app9173479
UT WoS 000488603600041
Keywords in English SLC22A12; URAT1; hypouricemia; uric acid transporters; excretion fraction of uric acid
Tags 14110317, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 17/2/2020 10:52.
Abstract
Renal hypouricemia (RHUC) is caused by an inherited defect in the main (reabsorptive) renal urate transporters, URAT1 and GLUT9. RHUC is characterized by decreased concentrations of serum uric acid and an increase in its excretion fraction. Patients suffer from hypouricemia, hyperuricosuria, urolithiasis, and even acute kidney injury. We report the clinical, biochemical, and genetic findings of a pediatric patient with hypouricemia. Sequencing analysis of the coding region of SLC22A12 and SLC2A9 and a functional study of a novel RHUC1 variant in the Xenopus expression system were performed. The proband showed persistent hypouricemia (67-70 mu mol/L; ref. range 120-360 mu mol/L) and hyperuricosuria (24-34%; ref. range 7.3 +/- 1.3%). The sequencing analysis identified common non-synonymous allelic variants c.73G > A, c.844G > A, c.1049C > T in the SLC2A9 gene and rare variants c.973C > T, c.1300C > T in the SLC22A12 gene. Functional characterization of the novel RHUC associated c.973C > T (p. R325W) variant showed significantly decreased urate uptake, an irregular URAT1 signal on the plasma membrane, and reduced cytoplasmic staining. RHUC is an underdiagnosed disorder and unexplained hypouricemia warrants detailed metabolic and genetic investigations. A greater awareness of URAT1 and GLUT9 deficiency by primary care physicians, nephrologists, and urologists is crucial for identifying the disorder.
PrintDisplayed: 21/7/2024 21:13